Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
5.89
-0.02 (-0.25%)
Jul 22, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $5.87 million as of July 22, 2026. Its market cap has decreased by -18.04% in one year.
Market Cap
5.87M
Enterprise Value
4.84M
1-Year Change
-18.04%
Ranking
Category
Stock Price
$5.89
ChartMarket Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $5.87M, a decrease of -98.19%. That is a compound annual growth rate of -18.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 5.87M | -28.17% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 6.22M |
| Pulmatrix | 6.21M |
| Evogene | 6.20M |
| Xenetic Biosciences | 6.19M |
| Processa Pharmaceuticals | 6.16M |
| BioAtla | 6.12M |
| Purple Biotech | 6.11M |
| CollPlant Biotechnologies | 6.05M |